Cargando…

Epigenetic Regulation of β-Globin Genes and the Potential to Treat Hemoglobinopathies through Epigenome Editing

Beta-like globin gene expression is developmentally regulated during life by transcription factors, chromatin looping and epigenome modifications of the β-globin locus. Epigenome modifications, such as histone methylation/demethylation and acetylation/deacetylation and DNA methylation, are associate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fontana, Letizia, Alahouzou, Zoe, Miccio, Annarita, Antoniou, Panagiotis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10048329/ https://www.ncbi.nlm.nih.gov/pubmed/36980849 http://dx.doi.org/10.3390/genes14030577

Ejemplares similares

Genome Editing for β-Hemoglobinopathies: Advances and Challenges
por: Frati, Giacomo, et al.
Publicado: (2021)

Editing the core region in HPFH deletions alters fetal and adult globin expression for treatment of β-hemoglobinopathies
por: Venkatesan, Vigneshwaran, et al.
Publicado: (2023)

Recent Approaches for Manipulating Globin Gene Expression in Treating Hemoglobinopathies
por: Mussolino, Claudio, et al.
Publicado: (2021)

Novel genome-editing-based approaches to treat motor neuron diseases: Promises and challenges
por: Miccio, Annarita, et al.
Publicado: (2022)

Base and Prime Editing Technologies for Blood Disorders
por: Antoniou, Panagiotis, et al.
Publicado: (2021)

Base-editing-mediated dissection of a γ-globin cis-regulatory element for the therapeutic reactivation of fetal hemoglobin expression
por: Antoniou, Panagiotis, et al.
Publicado: (2022)

Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene
por: Negre, Olivier, et al.
Publicado: (2016)

Rapid and Sensitive Assessment of Globin Chains for Gene and Cell Therapy of Hemoglobinopathies
por: Loucari, Constantinos C., et al.
Publicado: (2018)

Precision Editing as a Therapeutic Approach for β-Hemoglobinopathies
por: Paschoudi, Kiriaki, et al.
Publicado: (2023)

The GATA1-HS2 Enhancer Allows Persistent and Position-Independent Expression of a β-globin Transgene
por: Miccio, Annarita, et al.
Publicado: (2011)

β-Hemoglobinopathies: The Test Bench for Genome Editing-Based Therapeutic Strategies
por: Barbarani, Gloria, et al.
Publicado: (2020)

Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
por: Papizan, James B., et al.
Publicado: (2021)

Genomic approaches to identifying targets for treating β hemoglobinopathies
por: Ngo, Duyen A., et al.
Publicado: (2015)

β-Globin cis-elements determine differential nuclear targeting through epigenetic modifications
por: Bian, Qian, et al.
Publicado: (2013)

Gene Editing-Based Technologies for Beta-hemoglobinopathies Treatment
por: Rahimmanesh, Ilnaz, et al.
Publicado: (2022)

Editing a γ-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype
por: Weber, Leslie, et al.
Publicado: (2020)

Advances of Epigenetic Biomarkers and Epigenome Editing for Early Diagnosis in Breast Cancer
por: Sarvari, Pourya, et al.
Publicado: (2022)

Prenatal Diagnosis of β-Thalassemias and Hemoglobinopathies.
por: Rosatelli, Maria Cristina, et al.
Publicado: (2009)

Genetic and Epigenetic Therapies for β-Thalassaemia by Altering the Expression of α-Globin Gene
por: Mettananda, Sachith
Publicado: (2021)

Precise epigenomic editing with a SunTag-based modular epigenetic toolkit
por: Guhathakurta, Subhrangshu, et al.
Publicado: (2022)

Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease
por: Park, So Hyun, et al.
Publicado: (2019)

A Nonhuman Primate Transplantation Model to Evaluate Hematopoietic Stem Cell Gene Editing Strategies for β-Hemoglobinopathies
por: Humbert, Olivier, et al.
Publicado: (2017)

Animal models of β-hemoglobinopathies: utility and limitations
por: McColl, Bradley, et al.
Publicado: (2016)

Unexpected discovery of hemoglobinopathy C/β° thalassemia
por: Bouyarmane, Wafaa, et al.
Publicado: (2018)

Editorial: Mutation-Specific Gene Editing for Blood Disorders
por: Lederer, Carsten Werner, et al.
Publicado: (2021)

Concise Review: Epigenetic Regulation of Hematopoiesis: Biological Insights and Therapeutic Applications
por: Antoniani, Chiara, et al.
Publicado: (2017)

The phenomena of balanced effect between α-globin gene and of β-globin gene
por: Zhong, Liangying, et al.
Publicado: (2018)

Updates in Hemoglobinopathies
por: Al-Tonbary, Youssef, et al.
Publicado: (2013)

CRISPR-Mediated Epigenome Editing
por: Enríquez, Paul
Publicado: (2016)

Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia
por: Mettananda, Sachith, et al.
Publicado: (2017)

Quantitative Epigenetics Through Epigenomic Perturbation of Isogenic Lines
por: Johannes, Frank, et al.
Publicado: (2011)

Genome-based therapeutic interventions for β-type hemoglobinopathies
por: Karamperis, Kariofyllis, et al.
Publicado: (2021)

In vivo base editing by a single i.v. vector injection for treatment of hemoglobinopathies
por: Li, Chang, et al.
Publicado: (2022)

Nuclease-mediated gene editing by homologous recombination of the human globin locus
por: Voit, Richard A., et al.
Publicado: (2014)

Molecular Characterization and Expression of α-Globin and β-Globin Genes in the Euryhaline Flounder (Platichthys flesus)
por: Lu, Weiqun, et al.
Publicado: (2011)

Chemical and Light Inducible Epigenome Editing
por: Zhao, Weiye, et al.
Publicado: (2020)

Gene Therapy for Hemoglobinopathies
por: Cavazzana, Marina, et al.
Publicado: (2018)

Gene Therapy of the Hemoglobinopathies
por: Kunz, Joachim B., et al.
Publicado: (2020)

Hemoglobinopathy and COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Rare Combinational Hemoglobinopathies
por: Husan, Ammar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iiaspoo270lticet20lqvifuk3